Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR4 | Q13639 | 19/20 | 0.77 |
| ▸ | ACHE | P22303 | 15/20 | 0.77 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28366574 | 0.88 | HTR4 (0.77) | HTR4ACHESIGMAR1MEN1ALDH1A1 | |
| SCHEMBL17709626 | 0.87 | ACHE (1.00) | HTR4ACHESIGMAR1 | |
| SCHEMBL22022517 | 0.84 | HTR4 (0.71) | HTR4ACHESIGMAR1MEN1ALDH1A1 | |
| SCHEMBL17709622 | 0.81 | HTR4 (0.79) | HTR4ACHEMEN1ALDH1A1CYP2D6 | |
| SCHEMBL17709642 | 0.81 | HTR4 (0.67) | HTR4ACHESIGMAR1MEN1ALDH1A1 | |
| SCHEMBL28366736 | 0.76 | HTR4 (0.60) | HTR4ACHESIGMAR1MEN1ALDH1A1 | |
| SCHEMBL17709638 | 0.75 | HTR4 (1.00) | HTR4ACHESIGMAR1MEN1ALDH1A1 | |
| SCHEMBL17709636 | 0.75 | ACHE (1.00) | HTR4ACHESIGMAR1 | |
| SCHEMBL17709631 | 0.75 | ACHE (1.00) | HTR4ACHESIGMAR1 | |
| SCHEMBL21866064 | 0.75 | ACHE (1.00) | HTR4ACHESIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105705488-B | Compounds of acetylcholinesterase inhibitors and 5-hydroxytryptamine receptor 4 agonists, process for their preparation and pharmaceutical compositions thereof | 卡昂大学 | 2020-03-24 | — | — | CN | disclosed |